Literature DB >> 25893455

Leukemia cell mobilization: a road to eradication?

E A Copelan1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25893455     DOI: 10.1038/bmt.2015.78

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

1.  A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia.

Authors:  Jonathan M Gerber; B Douglas Smith; Brownhilda Ngwang; Hao Zhang; Milada S Vala; Laura Morsberger; Steven Galkin; Michael I Collector; Brandy Perkins; Mark J Levis; Constance A Griffin; Saul J Sharkis; Michael J Borowitz; Judith E Karp; Richard J Jones
Journal:  Blood       Date:  2012-01-19       Impact factor: 22.113

Review 2.  Mobilization of hematopoietic stem and leukemia cells.

Authors:  Mark A Schroeder; John F DiPersio
Journal:  J Leukoc Biol       Date:  2011-10-25       Impact factor: 4.962

3.  Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.

Authors:  Zhihong Zeng; Yue Xi Shi; Ismael J Samudio; Rui-Yu Wang; Xiaoyang Ling; Olga Frolova; Mark Levis; Joshua B Rubin; Robert R Negrin; Elihu H Estey; Sergej Konoplev; Michael Andreeff; Marina Konopleva
Journal:  Blood       Date:  2008-10-27       Impact factor: 22.113

4.  Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.

Authors:  Bruno Nervi; Pablo Ramirez; Michael P Rettig; Geoffrey L Uy; Matthew S Holt; Julie K Ritchey; Julie L Prior; David Piwnica-Worms; Gary Bridger; Timothy J Ley; John F DiPersio
Journal:  Blood       Date:  2008-12-02       Impact factor: 22.113

5.  Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia.

Authors:  Bob Löwenberg; Wim van Putten; Matthias Theobald; Jurg Gmür; Leo Verdonck; Pieter Sonneveld; Martin Fey; Harry Schouten; Georgine de Greef; Augustin Ferrant; Tibor Kovacsovics; Alois Gratwohl; Simon Daenen; Peter Huijgens; Marc Boogaerts
Journal:  N Engl J Med       Date:  2003-08-21       Impact factor: 91.245

Review 6.  The leukemic stem cell niche: current concepts and therapeutic opportunities.

Authors:  Steven W Lane; David T Scadden; D Gary Gilliland
Journal:  Blood       Date:  2009-04-28       Impact factor: 22.113

7.  Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia.

Authors:  Elwin J C Rombouts; Biljana Pavic; Bob Löwenberg; Rob E Ploemacher
Journal:  Blood       Date:  2004-03-30       Impact factor: 22.113

8.  Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma.

Authors:  John F DiPersio; Edward A Stadtmauer; Auayporn Nademanee; Ivana N M Micallef; Patrick J Stiff; Jonathan L Kaufman; Richard T Maziarz; Chitra Hosing; Stefan Früehauf; Mitchell Horwitz; Dennis Cooper; Gary Bridger; Gary Calandra
Journal:  Blood       Date:  2009-04-10       Impact factor: 22.113

9.  Leukemia cell mobilization with G-CSF plus plerixafor during busulfan-fludarabine conditioning for allogeneic stem cell transplantation.

Authors:  Marina Konopleva; Christopher B Benton; Peter F Thall; Zhihong Zeng; Elizabeth Shpall; Stefan Ciurea; Partow Kebriaei; Amin Alousi; Uday Popat; Paolo Anderlini; Yago Nieto; Simrit Parmar; Wei Qiao; Julianne Chen; Gabriela Rondon; Becky McMullin; Rui-Yu Wang; Hongbo Lu; Wendy Schober; Glenda Woodworth; Alison Gulbis; Rita Cool; Michael Andreeff; Richard Champlin
Journal:  Bone Marrow Transplant       Date:  2015-04-13       Impact factor: 5.483

10.  Leukemia propagating cells rebuild an evolving niche in response to therapy.

Authors:  Cai-Wen Duan; Jun Shi; Jing Chen; Bo Wang; Ye-Hua Yu; Xia Qin; Xiang-Cheng Zhou; Yi-Jun Cai; Zuo-Qing Li; Fang Zhang; Min-Zhi Yin; Ying Tao; Jian-Qing Mi; Lin-Heng Li; Tariq Enver; Guo-Qiang Chen; Deng-Li Hong
Journal:  Cancer Cell       Date:  2014-06-16       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.